祥生医疗：2025年度净利润约1.17亿元，同比下降16.99%

Group 1 - The core point of the article highlights that Xiangsheng Medical reported a revenue of approximately 447 million yuan for the year 2025, representing a year-on-year decrease of 4.55% [1] - The net profit attributable to shareholders of the listed company is approximately 117 million yuan, which reflects a year-on-year decline of 16.99% [1] - The basic earnings per share is reported at 1.04 yuan, showing a decrease of 17.46% compared to the previous year [1] Group 2 - The article also mentions a significant shift in AI usage, with China's AI call volume surpassing that of the United States for the first time, leading to a surge in various sectors in the A-share market [1] - A well-known Wall Street analyst commented on China's computing power path, suggesting it disrupts traditional perceptions [1]